AbbVie and Johnson & Johnson have resilient, noncyclical businesses. They are also outstanding dividend payers.
2 Healthcare Stocks That Can Diversify a Tech
Related Posts
Is Now the Time to Buy One of the Worst-Performing “Magnificent Seven” Stocks of 2025?
Up until last week, Amazon was the worst performer of the bunch so far in 2025.
2 Nuclear Energy Stocks That Could Be Going to $0, and 1 Generating Serious Portfolio Power
Nuclear power has gained significant investor interest, with the Global X Uranium ETF rising 65% over the past year.
Nvidia’s Earnings Are Almost Here. Here’s the State of the Magnificent 7 Stocks.
Can Nvidia keep the Big AI trade alive?